A Phase 2 Study to Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Elixiron Immunotherapeutics (Hong Kong) Ltd.
Weill Medical College of Cornell University
Inmune Bio, Inc.
Mayo Clinic
Helse Stavanger HF
Inmune Bio, Inc.
Boston Medical Center
Prothena Biosciences Ltd.